[Crataegus in cardiology].
The fact that the effectiveness of numerous phyto-preparations, so-called, has been demonstrated to the satisfaction of traditional medicine has led to increasing interest in phytotherapy. This also applies to Crataegus (whitethorn), the effects of which have been demonstrated in numerous pharmacological studies. These effects, produced mainly by the flavonoids, indicate a simultaneous cardiotropic and vasodilatory action, as confirmed clinically in controlled double-blind studies. This means that Crataegus can be employed for cardiological indications for which digitalis is not (yet) indicated. Prior to use, however, a Crataegus preparation must meet certain preconditions with respect to dosage, pharmaceutical quality of the preparation, and an accurate definition of the later.
Blesken
R
R
D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D010936:Plant Extracts / Q000627:therapeutic use*; D010946:Plants, Medicinal
D002316:Cardiotonic Agents; D010936:Plant Extracts
Crataegus in der Kardiologie.